Jump to content
Powered by BIOPRO BW
  • BIOPRO BW
  • Healthcare industry
  • Project pages
    • MDR & IVDR
    • Innovation & Startups

Healthcare industry Logo

Main navigation

  • Start page Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close Close
  • Databases

    Databases

    Close Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Press release - 16/06/2025

    Novel laboratory models pave the way for targeted therapies for childhood sarcomas

    Sarcomas in soft tissue usually occur in young people and are difficult to treat. Due to a lack of laboratory models, the causes of their development are poorly understood. A team of researchers has now succeeded in creating mouse models with a functioning immune system that replicate sarcoma types that remain unstudied. The method opens up new avenues for the targeted development of immunotherapies for children and adolescents with sarcomas.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/novel-laboratory-models-pave-way-targeted-therapies-childhood-sarcomas
  • Cell-based solution in place of animal testing - 05/06/2025 FB_Teaser_CellAlarm-InnoZell_.jpg

    Innovative cell-based test to detect pyrogens in drugs

    Drug safety testing for microbial contaminants and fever-inducing substances (pyrogens) still frequently uses animal experiments. InnoZell, a start-up that will soon be spun off from the University of Konstanz, has developed a compelling alternative: an animal-free, human cell-based assay that is faster, more sensitive and more reliable than traditional methods – and can be customised to meet user-specific needs.

    https://www.gesundheitsindustrie-bw.de/en/article/news/innovative-cell-based-test-detect-pyrogens-drugs
  • Press release - 22/05/2025

    Six Clusters of Excellence for the University of Tübingen

    Tübingen achieves remarkable success and has good chance of maintaining its University of Excellence title – Top research in three areas to be sustained from other sources of support.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/six-clusters-excellence-university-tubingen
  • Press release - 21/05/2025

    How aging changes the blood system in humans and mice

    The reservoir of blood stem cells shrinks with age. It becomes increasingly dominated by stem cells that produce immune cells associated with chronic inflammation. Almost all of the 60-year-olds studied show this change. The new discovery could help explain the chronic inflammation that occurs with age and makes us more susceptible to disease. It could also help identify early warning signs of unhealthy aging processes.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-aging-changes-blood-system-humans-and-mice
  • Press release - 19/05/2025

    How the Epstein-Barr virus promotes its spread in the body

    Many people are infected with the Epstein-Barr virus (EBV), and most are unaware of it. However, EBV can sometimes cause cancer, and this pathogen also appears to play an important role in multiple sclerosis and other autoimmune diseases. Researchers have discovered that EBV increases the ability of infected immune cells to migrate. In this way, the pathogen promotes its spread in the body – a discovery that may have therapeutic implications.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-epstein-barr-virus-promotes-its-spread-body
  • Life-saving smartphone app delivers rapid help during cardiac arrest - 19/05/2025 A section of a three-dimensional city map shows the routes taken by the first responders to the scene of the emergency.

    Do smartphone-based first responder alerting systems increase the chances of survival in the event of cardiac arrest?

    Every minute counts when the heart suddenly stops beating or pumps so weakly that the brain is no longer receiving enough oxygen. The HEROES trial, coordinated in Freiburg, is investigating whether the survival rate of patients requiring out-of-hospital resuscitation improves when qualified first responders are alerted via the ‘Region of Lifesavers’ app - enabling them to begin high-quality resuscitation measures as early as possible.

    https://www.gesundheitsindustrie-bw.de/en/article/news/do-smartphone-based-first-responder-alerting-systems-increase-chances-survival-event-cardiac-arrest
  • Press release - 15/05/2025

    Ground-breaking ceremony for new Cyber Valley building in Stuttgart

    A building with 7400 m² of research space for robotics and artificial intelligence is being built on the Max Planck Campus in Büsnau. Researchers from the Max Planck Institute for Intelligent Systems (MPI-IS) and the University of Stuttgart will be working there with partners from science and industry as well as start-ups from 2027.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/ground-breaking-ceremony-new-cyber-valley-building-stuttgart
  • Press release - 13/05/2025

    Award for Outstanding Contributions to Cancer Research

    Dr Dr Varun Venkataramani and Dr Moritz Mall have been awarded this year’s Hella Bühler Prize for their outstanding research on the interaction between nerve and tumor cells and on tumor plasticity. The award granted by Heidelberg University goes to young researchers from the Heidelberg research location who have already drawn attention to themselves through the outstanding scientific quality of their cancer research.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/award-outstanding-contributions-cancer-research
  • Press release - 12/05/2025

    NMI expertise for new VDI guideline on bioprinting - now available

    VDI Guideline 5708 “Bioprinting, methods and definitions”: What sounds technical and sober at first glance is an important step forward in the future field of 3D bioprinting. The guideline was developed under Dr. Hanna Hartmann from the NMI in Reutlingen and Prof. Dr. Jürgen Groll from the University Hospital of Würzburg. It creates a binding, practical basis for reproducible and quality-assured bioprinting procedures.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/nmi-expertise-new-vdi-guideline-bioprinting-now-available
  • Press release - 08/05/2025

    Childhood brain tumors develop early in highly specialized nerve cells

    Medulloblastomas, childhood brain tumors in children, are thought to develop between the first trimester of pregnancy and the end of the first year of life. Researchers have now published their findings in the journal Nature. They analyzed the genetic changes of each individual cancer cell in tumor samples in order to reconstruct which genetic changes occur first during tumor development and when.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/childhood-brain-tumors-develop-early-highly-specialized-nerve-cells
  • Press release - 07/05/2025

    Contactless. Precise. Pioneering: Muscle Monitoring with Quantum Sensors

    A research team led by PD Dr. Justus Marquet and from the Hertie Institute for Clinical Brain Research has developed two methods that allow muscle activity and training-induced adaptations to be measured completely contactlessly. The studies demonstrate that magnetic fields generated during muscle activity can be captured using highly sensitive quantum sensors - without the need for electrodes or skin contact.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/contactless-precise-pioneering-muscle-monitoring-quantum-sensors
  • Press release - 30/04/2025

    HFU Skills4MedTec project starts 2025

    This year Furtwangen University (HFU) is launching the “HFU Skills4MedTec” project to further enhance its profile as a leading authority in medical technology and to develop targeted scientific training courses for specialists and managers in the industry.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/hfu-skills4medtec-project-starts-2025
  • New treatment methods: DNA origami-based nanodevices precisely control immune response - 24/04/2025 Hydroborierung_synthetische-Immunologie.png

    Bottom-up synthetic immunology for novel therapeutic approaches

    Modern therapies for combating cancer and infectious diseases increasingly leverage the body’s own immune system. Several research groups at Heidelberg University are using innovative bottom-up approaches in synthetic immunology to develop new treatment methods that can control the immune response more precisely than previously possible.

    https://www.gesundheitsindustrie-bw.de/en/article/news/bottom-synthetic-immunology-novel-therapeutic-approaches
  • Press release - 16/04/2025

    Hereditary Alzheimer’s: Blood Marker for Defective Neuronal Connections Rises Early

    Individuals with a genetic predisposition to Alzheimer’s disease show altered blood levels indicating damaged neuronal contacts as early as 11 years before the expected onset of dementia symptoms. This is evident in the levels of the protein “beta-synuclein”. An international team report these findings in the journal “Alzheimer’s & Dementia”. The biomarker studied here could potentially help to detect neurodegeneration at an early stage.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/hereditary-alzheimers-blood-marker-defective-neuronal-connections-rises-early
  • Press release - 10/04/2025

    In future, the operating theatre will be part of the team

    The “Digital Integration and Innovation in Surgery” project aims to promote the transfer of new findings and research results into practice. The School of Informatics at Reutlingen University will work together with Furtwangen University, BioMedTech e.V., University Hospital Tübingen and other stakeholders to examine how intelligent digital assistance systems can contribute to improved patient care during surgical procedures.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/future-operating-theatre-will-be-part-team
  • Press release - 09/04/2025

    The positive effect of paws Pets reduce the risk of stress-related disorders in city dwellers

    Contact with pets reduces the risk of developing stress-related disorders in adult life in urban children. This is the conclusion of a study conducted by the Section for Molecular Psychosomatic Medicine at Ulm University Hospital together with other researchers from Germany and the USA. Living with animals is said to alleviate inflammatory stress reactions.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/positive-effect-paws-pets-reduce-risk-stress-related-disorders-city-dwellers
  • Press release - 08/04/2025

    Freiburg cancer researcher receives the German Cancer Award 2025

    Melanie Börries, Professor of Medical Bioinformatics at the Medical Faculty of the University of Freiburg and Director of the Institute of Medical Bioinformatics and Systems Medicine at the Medical Center – University of Freiburg, is being honoured for her pioneering work in personalised cancer therapy.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/freiburg-cancer-researcher-receives-german-cancer-award-2025
  • Baden-Württemberg AI Alliance - 08/04/2025 There are two large computer screens on a desk with a computer mouse and keyboard. The screens show a stylized human head and a head in which parts of the brain structure are stylized. They are surrounded by a network.

    Achieving widespread use of AI

    Artificial intelligence presents both opportunities and risks. The Baden-Württemberg AI Alliance is dedicated to fostering collaboration among AI stakeholders to ensure that AI solutions deliver tangible benefits to citizens and businesses across the state. The alliance will also place greater emphasis on advancing AI applications within the healthcare sector.

    https://www.gesundheitsindustrie-bw.de/en/article/news/achieving-widespread-use-ai
  • Press release - 07/04/2025

    Interdisciplinary research to provide urgently needed insecticides to combat malaria

    The Medical Faculty Heidelberg of Heidelberg University and Mannheim University of Applied Sciences are combining their expertise in infectious disease research, mass spectrometry, and bioinformatics to overcome resistance in malaria vectors. The project is supported by funding from the Gates Foundation.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/interdisciplinary-research-provide-urgently-needed-insecticides-combat-malaria
  • Press release - 03/04/2025

    Heinz Maier-Leibnitz Prize for Lukas Bunse

    Germany's most important award for young scientists honors the development of immunotherapies against malignant brain tumors.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/heinz-maier-leibnitz-prize-lukas-bunse
  • Press release - 02/04/2025

    New antibiotic for multidrug resistant superbug

    Researchers from the universities in Konstanz and Vienna discover a new class of antibiotic that selectively targets Neisseria gonorrhoeae, the bacterium that causes gonorrhoea. These substances trigger a self-destruction program, which also operates in multi-resistant variants of the pathogen. The novel findings are published in the current issue of Nature Microbiology.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-antibiotic-multidrug-resistant-superbug
  • Press release - 28/03/2025

    Quality Assurance in the Cell: Preventing Defective Protein Blueprints

    Two molecular control factors play a decisive role in what is known as splicing, the cutting and assembly of mature messenger RNA – a prerequisite for protein synthesis in the cell. The poorly characterized factors are crucial to ensuring that the molecular machine responsible for splicing is working correctly. A research team has deciphered how the two cellular quality inspectors work.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/quality-assurance-cell-preventing-defective-protein-blueprints
  • Press release - 21/03/2025

    Risk-based assessment of AI in medicine

    A recent article by Prof. Dr. Martin Haimerl and Prof. Dr. Christoph Reich of Furtwangen University shows that machine learning (ML) in medicine is often evaluated without a comprehensive risk assessment. The authors investigated the extent to which current scientific papers include risk-based metrics in the evaluation of AI models for medical devices.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/risk-based-assessment-ai-medicine
  • Press release - 20/03/2025

    Start-up prize for "EmbryoNet AI Technologies"

    Using artificial intelligence to revolutionize drug development is the aim of the start-up "EmbryoNet AI Technologies" led by Konstanz biologist Patrick Müller. Müller and his team have now been awarded the start-up prize by the Federal Ministry for Economic Affairs and Climate Action (BMWK) for their business concept.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/start-prize-embryonet-ai-technologies
  • Press release - 19/03/2025

    Pocket-sized breath test for stomach bacteria Mini sensor analyses breath for infection with Helicobacter pylori

    Stomach ulcers, gastritis and even stomach cancer are often the result of an infection with Helicobacter pylori. If the bacterium remains unrecognised for a long time, this can have serious consequences. Researchers have now developed a miniaturisable sensor system for the mobile analysis of breath that is effective, fast and inexpensive. The research team uses a biological survival trick of the stomach germ to detect the bacterium.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/pocket-sized-breath-test-stomach-bacteria-mini-sensor-analyses-breath-infection-helicobacter-pylori
  • Press release - 18/03/2025

    Maternal overweight as risk factor for childhood leukemia in daughters

    The weight of expectant mothers could play a role in the development of acute lymphoblastic leukemia (ALL) in daughters – but not in sons. This has been shown by researchers at the German Cancer Research Center (DKFZ).

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/maternal-overweight-risk-factor-childhood-leukemia-daughters
  • Press release - 17/03/2025

    New approach for T-cell immunotherapy against malignant brain tumors

    Researchers have developed a promising cellular immunotherapy for the treatment of glioblastomas: They equipped T cells with a receptor that recognizes a protein of the brain tumors that is responsible for the dangerous stem cell properties. The therapeutic T cells directed against this target structure were able to specifically destroy human brain tumors in laboratory experiments and in mice.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-approach-t-cell-immunotherapy-against-malignant-brain-tumors
  • Press release - 17/03/2025

    RNA Origami: Artificial Cytoskeletons to Build Synthetic Cells

    With the goal of creating living cells from non-living components, scientists in the field of synthetic biology work with RNA origami. This tool uses RNA biomolecule to fold new building blocks, making protein synthesis superfluous. In pursuit of the artificial cell, a research team has cleared a crucial hurdle. Using the new RNA origami technique, they succeeded in producing nanotubes that fold into cytoskeleton-like structures.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/rna-origami-artificial-cytoskeletons-build-synthetic-cells
  • Press release - 14/03/2025

    Tool identifies specific viruses to combat dangerous bacteria

    University of Tübingen research team shortens the search for attackers that can wipe out multiresistant pathogens – with the aim of treating infections without antibiotics

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/tool-identifies-specific-viruses-combat-dangerous-bacteria
  • Press release - 13/03/2025

    Dieter Schwarz Foundation provides long-term funding for application-oriented basic research and innovative talent pool

    The Max Planck Society and the Dieter Schwarz Foundation (DSS) have embarked on a groundbreaking initiative. On March 13, 2025, they signed an agreement through which the foundation will support an innovative approach by the Max Planck Institute for Medical Research in Heidelberg to translate basic research findings into practical applications. As part of this endeavour, two new departments of the institute will be established in Heilbronn.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/dieter-schwarz-foundation-provides-long-term-funding-application-oriented-basic-research-and-innovative-talent-pool
  • Microorganisms produce nutrients in bioreactors - 12/03/2025 A bioreactor in a laboratory with a glass vessel containing a liquid with harvested yeast.

    CO2 and H2 as starting materials for proteins and vitamins

    Agricultural land needed to sustain the world's growing population is becoming increasingly scarce. To help address this challenge, researchers from the Environmental Biotechnology Group at the University of Tübingen have developed an innovative and sustainable power-to-vitamin technology. This breakthrough enables protein- and vitamin-rich foods to be produced with the help of microorganisms in a bioreactor using carbon dioxide and…

    https://www.gesundheitsindustrie-bw.de/en/article/news/co2-and-h2-starting-materials-proteins-and-vitamins
  • Press release - 12/03/2025

    Hepatic stellate cells control liver function and regeneration

    Until now, doctors knew hepatic stellate cells mainly as drivers of liver fibrosis. The actual functions have hardly been studied to date. Researchers from the German Cancer Research Center, the Mannheim Medical Faculty and Columbia University have now published that hepatic stellate cells control liver metabolism as well as liver regeneration and size. The results of the study could contribute to new therapeutic approaches for liver diseases.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/hepatic-stellate-cells-control-liver-function-and-regeneration
  • Press release - 06/03/2025

    NMI TT in Reutlingen and Düsseldorf University Women's Hospital develop high-precision method for analyzing individual circulating tumor cells

    Researchers have developed a new method that enables a more precise analysis of individual tumor cells circulating in the blood. This allows not only the previously possible genomic investigation of such tumor cells, but also the focused analysis of single-cell signaling pathways at the functional protein level. The combined analysis of the mutated genome and signaling proteins opens up new avenues for more targeted treatment methods.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/nmi-tt-reutlingen-and-duesseldorf-university-womens-hospital-develop-high-precision-method-analyzing-individual-circulating-tumo
  • Press release - 06/03/2025

    Artificial Muscles for Tremor Suppression

    Scientists at the Max Planck Institute for Intelligent Systems, the University of Tübingen and the University of Stuttgart under the Bionic Intelligence Tübingen Stuttgart (BITS) collaboration developed a biorobotic arm that can mirror human tremors. Artificial muscles on either side of the forearm contract and relax to suppress the involuntary shaking of the wrist and hand.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/artificial-muscles-tremor-suppression
  • Press release - 05/03/2025

    Frank Winkler receives the Brain Prize 2025

    This year, the Brain Prize worth more than one million euros, honors pioneering work on nervous system-cancer interactions: Neurologist Frank Winkler, who researches at the Heidelberg University and at the German Cancer Research Center and treats patients with brain tumors at the Heidelberg University Hospital, discovered that nerve cells in the brain communicate with brain tumor cells. This causes the disease to progress.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/frank-winkler-receives-brain-prize-2025
  • Press release - 04/03/2025

    Clusters of Metabolic Dysfunction-Associated Steatotic Liver Disease for Precision Medicine

    People with metabolic dysfunction-associated steatotic liver disease (MASLD) and more so with metabolic dysfunction-associated steatohepatitis and MASLD-associated hepatic fibrosis can progress to cirrhosis and hepatocellular carcinoma and are at increased risk of developing type 2 diabetes, cardiovascular and chronic kidney disease, and cancers. Future research might be beneficial for implementing precision medicine in MASLD.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/clusters-metabolic-dysfunction-associated-steatotic-liver-disease-precision-medicine
  • Press release - 28/02/2025

    Recognise developmental disorders early with AI: Automatically classifying movement patterns in babies

    Using a new combination of three sensors and artificial intelligence, researchers at Heidelberg Medical Faculty of Heidelberg University and Heidelberg University Hospital are recognising patterns in babies' movements that show whether their nervous system is developing healthily.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/recognise-developmental-disorders-early-ai-automatically-classifying-movement-patterns-babies
  • Press release - 28/02/2025

    Scientists discover the function of a mysterious HIV component

    A research team including scientists from Heidelberg University Hospital has gained new insights into HIV-1. Researchers have discovered the mechanism behind an important step in the life cycle of HIV. Working together with teams at Heidelberg and Yale Universities, they found that the enigmatic “spacer peptide 2”, one of the virus components, plays a key role in converting immature HIV-1 particles into infectious particles.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/scientists-discover-function-mysterious-hiv-component
  • Press release - 27/02/2025

    EU Project: New Molecular Interventions against Virus Infections

    Targeted molecular interventions in the replication cycle and the immune recognition of viruses are intended to prevent viral entry into cells and virus replication. Scientists work on new approaches to combating highly dangerous viral diseases such as yellow fever or Lassa fever. The European Union is supporting the project over a period of five years to the tune of just under eight million euros.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/eu-project-new-molecular-interventions-against-virus-infections
  • Press release - 25/02/2025

    Self-healing hearts How Zebrafish regenerate heart muscle cells

    Zebrafish can completely replace damaged heart muscle cells: The affected organ becomes fully functional again. Researchers at Ulm University have discovered that a specific cell-to-cell communication signal helps them to cope better with replication stress. This stress inhibits tissue regeneration in humans and mammals as they age. In Zebrafish a signalling protein ensures that the cells of the damaged organ continue to divide and thus multiply.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/self-healing-hearts-how-zebrafish-regenerate-heart-muscle-cells
  • Press release - 25/02/2025

    Protein with contradictory properties: secret revealed

    A protein with contradictory properties: Despite its large negative surface charge, it has a strong tendency to take up electrons, which are also negatively charged. The researchers discovered positively charged calcium ions inside the protein very near the electrons, counteracting their charge. They see this as a natural way of handling opposing electrical charges and allowing the protein to optimally fulfill its biological function.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/protein-contradictory-properties-secret-revealed
  • Press release - 17/02/2025

    Pancreatic cancer: blocked nerves as a possible new treatment strategy

    Pancreatic cancer is fueled by connections to the nervous system. This is reported by scientists from the German Cancer Research Center (DKFZ) and the Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM)*. The team discovered that the tumor reprograms the neurons for its own benefit.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/pancreatic-cancer-blocked-nerves-possible-new-treatment-strategy
  • Press release - 12/02/2025

    Therapeutic Designer Peptide to Combat Acute Heart Muscle Weakness

    Researchers of the Heidelberg University, Heidelberg University Hospital (UKHD) and Heidelberg Institute for Theoretical Studies (HITS) have developed a synthetic peptide based on the natural protein S100A1, a nearly universal “fuel” for weakened hearts. The researchers combined computer-aided methods with lab studies to investigate the therapeutic effect of the so called S100A1ct peptide molecule.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/therapeutic-designer-peptide-combat-acute-heart-muscle-weakness
  • Press release - 11/02/2025

    New perspectives for personalized therapy of brain tumors

    Scientists from the German Cancer Research Center (DKFZ) and ShanghaiTech University have developed an innovative method for growing brain tumors of individual patients in the laboratory that mimic the original structure and the molecular property of the parental tumor as closely as possible. Drug tests in this model were found to correlate very well with actual patient responses, making it a valuable method for investigating therapies.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-perspectives-personalized-therapy-brain-tumors
  • Press release - 07/02/2025

    Spliceosome: How cells avoid errors when manufacturing mRNA

    The spliceosome, ensures that the genetic information from the genome, after being transcribed into mRNA precursors, is correctly assembled into mature mRNA. Splicing is a basic requirement for producing proteins. Researchers at the Heidelberg University Biochemistry Center (BZH) have succeeded for the first time in depicting a faultily “blocked” spliceosome at high resolution and reconstructing how it is recognized and eliminated in the cell.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/spliceosome-how-cells-avoid-errors-when-manufacturing-mrna
  • Press release - 07/02/2025

    Multiple myeloma: When cancer cells break out of the bone marrow, a dangerous diversity arises

    A research team from the Heidelberg Medical Faculty, the German Cancer Research Center, the Berlin Institute of Health at Charité (BIH) and the Max Delbrück Center has discovered new details about the spread of the incurable bone marrow cancer multiple myeloma in the body: When the cancer cells break out of the bone and multiply outside the bone marrow, a wide variety of tumor cells arise, accompanied by a significantly altered immune response.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/multiple-myeloma-when-cancer-cells-break-out-bone-marrow-dangerous-diversity-arises
  • Project REVeyeVE - 06/02/2025 Es ist eine einzelne gedrehte, helle Struktur vor schwarzem Hintergrund zu sehen.

    Targeted, virus-free gene therapy for the eye using degradable nanopropellers

    Eye diseases that result in blindness in young people are primarily caused by genetic mutations. An interdisciplinary team of researchers from the Universities of Tübingen and Heidelberg is developing an innovative gene therapy method using biodegradable, magnetic nanopropellers. These innovative nanopropellers can effectively deliver intact genes into the affected cells, offering a potential solution for treating genetic disorders of this kind.

    https://www.gesundheitsindustrie-bw.de/en/article/news/Targeted-virus-free-gene-therapy-for-the-eye-using-degradable-nanopropellers
  • Press release - 23/01/2025

    How the Ebola virus replicates in cells

    Like all viruses, the Ebola virus is dependent on host cells in order to replicate. Researchers at Heidelberg University Hospital, in collaboration with colleagues from the Friedrich Loeffler Institute, have been able to show for the first time using state-of-the-art imaging techniques how the replication compartments of the Ebola virus change during replication in infected cells.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/how-ebola-virus-replicates-cells
  • Press release - 23/01/2025

    ERC Funding for „EmbryoNet-AI“

    Konstanz biologist Patrick Müller receives a Proof of Concept Grant from the European Research Council for his project "EmbryoNet-AI". Its goal is the further development of an AI-supported platform for the automated evaluation of experiments – for example, in drug development.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/erc-funding-embryonet-ai
  • Press release - 20/01/2025

    PAMSARC: New study at the NCT Heidelberg links research and clinical action

    Young patients suffering from two aggressive sarcoma types can now participate in the innovative PAMSARC therapy study at the NCT Heidelberg. The study uses molecular biological methods and tests the extent to which a new drug can improve the poor prognosis for these tumours.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/pamsarc-new-study-nct-heidelberg-links-research-and-clinical-action

Page 1 / 9

sb_search.block.search_result.other.pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 9
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • MDR & IVDR
    • Innovation & Startups
  • Portals
    • BIOPRO BW
    • Healthcare industry
  • To top

stay informed

Newsletter abonnieren

Social Media

  • Xing Xing
  • Twitter visit Twitter
  • LinkedIn visit LinkedIn
  • Rss visit RSS
  • Privacy statement
  • Accessability Declaration
  • Legal notice
  • Sitemap
  • Contact
© 2025
Website address: https://www.gesundheitsindustrie-bw.de/en/search